Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$346M |
| 2 |
Broadcom
AVGO
|
+$326M |
| 3 |
Boeing
BA
|
+$263M |
| 4 |
Capital One
COF
|
+$258M |
| 5 |
Occidental Petroleum
OXY
|
+$257M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$550M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$549M |
| 3 |
Apple
AAPL
|
+$506M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$296M |
| 5 |
CSX Corp
CSX
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Financials | 5.63% |
| 3 | Consumer Discretionary | 5.39% |
| 4 | Healthcare | 4.82% |
| 5 | Industrials | 4.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
PUT
Sarepta Therapeutics
SRPT
$1.91B
| $2.75M | ﹤0.01% |
81,700
-6,400
| -7% | -$208K |
|
|
GOV
2602
DELISTED
Government Properties Income Trust
GOV
| $2.75M | ﹤0.01% |
150,432
+60,009
| +66% | +$1.31M |
|
2603
CALL
ASML
ASML
$708B
| $2.75M | ﹤0.01% |
21,100
+12,700
| +151% | +$1.68M |
|
|
KND
2604
DELISTED
Kindred Healthcare
KND
| $2.75M | ﹤0.01% |
236,009
-79,057
| -25% | -$779K |
|
|
GNCMA
2605
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $2.75M | ﹤0.01% |
+75,000
| New | +$2.71M |
|
2606
CALL
Cigna
CI
$74.7B
| $2.75M | ﹤0.01% |
16,400
+6,600
| +67% | +$1.06M |
|
2607
CALL
Ferrari
RACE
$72.9B
| $2.74M | ﹤0.01% |
31,900
+17,400
| +120% | +$1.43M |
|
2608
PUT
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$534M
| $2.74M | ﹤0.01% |
2,944
+1,106
| +60% | +$1.1M |
|
2609
Unifirst Corp
UNF
$5.19B
| $2.74M | ﹤0.01% |
19,467
+17,964
| +1,195% | +$2.5M |
|
2610
PUT
iShares Russell 2000 Growth ETF
IWO
$15.2B
| $2.73M | ﹤0.01% |
16,200
-8,600
| -35% | -$1.42M |
|
2611
Badger Meter
BMI
$3.79B
| $2.73M | ﹤0.01% |
68,494
-5,242
| -7% | -$203K |
|
2612
CALL
Toronto Dominion Bank
TD
$205B
| $2.73M | ﹤0.01% |
54,100
-34,300
| -39% | -$1.65M |
|
|
IPHS
2613
DELISTED
Innophos Holdings, Inc.
IPHS
| $2.72M | ﹤0.01% |
62,035
-12,690
| -17% | -$570K |
|
2614
Albemarle
ALB
$16.1B
| $2.71M | ﹤0.01% |
+25,712
| New | +$2.8M |
|
|
RDS.A
2615
PUT
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.71M | ﹤0.01% |
51,000
-31,281
| -38% | -$1.66M |
|
2616
PUT
ProShares UltraShort Bloomberg Crude Oil
SCO
$594M
| $2.71M | ﹤0.01% |
783
+242
| +45% | +$786K |
|
|
VG
2617
DELISTED
Vonage Holdings Corporation
VG
| $2.71M | ﹤0.01% |
413,631
+117,832
| +40% | +$787K |
|
2618
PUT
Omega Healthcare
OHI
$14.1B
| $2.7M | ﹤0.01% |
81,900
+54,200
| +196% | +$1.79M |
|
|
NLSN
2619
CALL
DELISTED
Nielsen Holdings plc
NLSN
| $2.7M | ﹤0.01% |
69,900
+23,900
| +52% | +$949K |
|
2620
PUT
S&P Global
SPGI
$123B
| $2.7M | ﹤0.01% |
18,500
-13,500
| -42% | -$1.87M |
|
|
MDP
2621
DELISTED
Meredith Corporation
MDP
| $2.7M | ﹤0.01% |
45,374
+40,951
| +926% | +$2.39M |
|
2622
iShares MSCI ACWI ETF
ACWI
$33.6B
| $2.7M | ﹤0.01% |
41,161
-782,204
| -95% | -$50.8M |
|
2623
FlexShares International Quality Dividend Index Fund
IQDF
$1.17B
| $2.7M | ﹤0.01% |
107,061
-179,305
| -63% | -$4.49M |
|
2624
HSBC
HSBC
$356B
| $2.69M | ﹤0.01% |
63,586
-48,540
| -43% | -$1.88M |
|
|
AXON
2625
CALL
Axon Enterprise
AXON
$49.8B
| $2.69M | ﹤0.01% |
107,000
+15,400
| +17% | +$377K |
|
Similar funds
Ken Griffin's Q2 2017 Portfolio in Review
As of Q2 2017, Ken Griffin held 8,702 positions worth $118B, up 7.8% from $109B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ken Griffin's Q2 2017 filing shows 1,333 new, 3,126 increased, 2,721 reduced and 1,293 closed positions. Its largest new stake was Equity Residential: 2,436,064 shares worth $160M. The largest sale was Walt Disney, an estimated $550M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.4% a quarter earlier, followed by Financials and Consumer Discretionary.
- Ken Griffin's largest Q2 2017 buy was Equity Residential: 2,436,064 shares worth $160M.
- Ken Griffin added most to Applied Materials in Q2 2017, an estimated $346M increase.
- Ken Griffin's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $549M.
- Ken Griffin fully exited Walt Disney in Q2 2017, selling an estimated $550M.
- Ken Griffin's ten largest holdings make up 17% of its $118B portfolio in Q2 2017.
- Ken Griffin opened 1,333 new positions and closed 1,293 in Q2 2017.
- Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $118B.
Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.